Use of leukotriene antagonists for producing cytoprotective pharmaceutical compositions and process for producing cytoprotective pharmaceutical compositions
申请人:Merck & Co., Inc.
公开号:EP0156233A2
公开(公告)日:1985-10-02
Leukotriene antagonists have been found to be useful for inducing cytoprotection via an unspecified mechanism. Specific therapeutic utilities include, erosive gastritis, erosive esophagitis, inflammatory bowel disease, and induced hemorrhagic gastric erosions such as those caused by indomethacin or ethanol.
The leukotriene antagonists are used to produce cytoprotective pharmaceutical compositions. In a process for producing cytoprotective pharmaceutical compositions the leukotriene antagonists are incorporated into a corresponding composition in a cytoprotective effective amount.
Compounds of the Formulae:
and
are antagonists of leukotrienes of C4, D4 and E4, the slow reacting substance of anaphylaxis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents.
这些化合物可用作抗哮喘、抗过敏、抗炎和细胞保护剂。
Leukotriene antagonists, their production, and compositions containing them
申请人:MERCK FROSST CANADA INC.
公开号:EP0104885B1
公开(公告)日:1986-06-04
US5135940A
申请人:——
公开号:US5135940A
公开(公告)日:1992-08-04
Design and synthesis of sodium (.beta.R*,.gamma.S*)-4-[[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propyl]thio]-.gamma.-hydroxy-.beta.-methylbenzenebutanoate: a novel, selective, and orally active receptor antagonist of leukotriene D4
作者:R. N. Young、P. Belanger、E. Champion、R. N. DeHaven、D. Denis、A. W. Ford-Hutchinson、R. Fortin、R. Frenette、J. Y. Gauthier